Skip to main content
Industry News
Taysha gene therapy nabs orphan drug, rare pediatric tags

Taysha Gene Therapies announced that the FDA granted both the rare pediatric disease and orphan drug designations to its investigational gene therapy TSHA-102 designed to treat Rett syndrome. The company is expected to file an investigational new drug application for the gene therapy in 2021.

Full Story: